NCT05514132 2026-03-09A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid TumoursAstraZenecaPhase 1 Active not recruiting14 enrolled
NCT06929260 2026-01-22A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug ZAstraZenecaPhase 1 Terminated1 enrolled